Armata Pharmaceuticals, Inc. (ARMP) › Net IncomeArmata Pharmaceuticals, Inc. (ARMP) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$64.58M2014: $23.11M2015: -$516.0K2016: -$18.84M2017: -$12.84M2018: -$16.70M2019: -$19.48M2020: -$22.18M2021: -$23.16M2022: -$36.92M2023: -$69.05M2024: -$18.92M2025: -$173.80M-$173.80M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$173.80M-818.8%2024-$18.92M+72.6%2023-$69.05M-87.0%2022-$36.92M-59.4%2021-$23.16M-4.4%2020-$22.18M-13.9%2019-$19.48M-16.6%2018-$16.70M-30.1%2017-$12.84M+31.9%2016-$18.84M-3550.8%2015-$516.0K-102.2%2014$23.11M+135.8%2013-$64.58M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share